Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124977 |
TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2021-01-22 | 2021-09-02 | 132261 |
TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2022-02-17 | 2022-05-26 | 155177 |
TEVA-LACOSAMIDE | 100MG | TABLET | Resolved | 2019-09-26 | 2019-11-14 | 94831 |
TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2019-10-03 | 2019-10-10 | 95387 |
TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2019-12-05 | 2020-04-02 | 100296 |
TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2020-01-30 | 2020-04-02 | 104899 |
TEVA-LACOSAMIDE | 100MG | TABLET | Resolved | 2020-03-19 | 2020-04-02 | 109050 |
TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2021-04-29 | 2021-06-24 | 138323 |
TEVA-LACOSAMIDE | 100MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140399 |
TEVA-LACOSAMIDE | 200MG | TABLET | Resolved | 2022-05-12 | 2022-05-26 | 160442 |
TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2023-06-08 | 2023-06-27 | 194194 |
TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2023-06-19 | 2023-06-27 | 195446 |
TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2024-03-18 | 2024-05-30 | 222575 |
TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2017-08-21 | 2017-10-10 | 19964 |
TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-02-02 | 2023-04-28 | 183401 |
TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-03 | 195766 |
TEVA-LACTULOSE | 667MG | SOLUTION | Actual shortage | 2024-03-21 | 2024-03-21 | 222952 |
TEVA-LAMOTRIGINE | 100MG | TABLET | Resolved | 2017-04-03 | 2017-05-10 | 5204 |
TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-02 | 2021-01-28 | 88177 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |